Ianiro, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 5.037
NA - Nord America 4.662
AS - Asia 886
SA - Sud America 62
AF - Africa 25
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 10.694
Nazione #
US - Stati Uniti d'America 4.595
DE - Germania 1.732
IT - Italia 979
SE - Svezia 888
CN - Cina 544
IE - Irlanda 310
UA - Ucraina 303
FR - Francia 242
GB - Regno Unito 186
PL - Polonia 113
IN - India 108
FI - Finlandia 96
TR - Turchia 63
CA - Canada 57
BR - Brasile 45
JP - Giappone 33
NL - Olanda 30
BE - Belgio 28
HK - Hong Kong 28
IR - Iran 26
CZ - Repubblica Ceca 25
ES - Italia 23
CH - Svizzera 20
SG - Singapore 20
RU - Federazione Russa 15
AU - Australia 11
KR - Corea 9
CL - Cile 8
IQ - Iraq 8
TN - Tunisia 8
CI - Costa d'Avorio 7
EU - Europa 7
PT - Portogallo 7
RO - Romania 7
AT - Austria 6
VN - Vietnam 6
GR - Grecia 5
TW - Taiwan 5
CO - Colombia 4
CY - Cipro 4
EC - Ecuador 4
HR - Croazia 4
IL - Israele 4
LK - Sri Lanka 4
PH - Filippine 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
MX - Messico 3
MY - Malesia 3
AL - Albania 2
BY - Bielorussia 2
BZ - Belize 2
CR - Costa Rica 2
EG - Egitto 2
HU - Ungheria 2
JO - Giordania 2
LT - Lituania 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
YE - Yemen 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 10.694
Città #
Chandler 1.043
Ashburn 381
Dublin 308
San Mateo 193
Ann Arbor 184
Jacksonville 179
Cattolica 142
Wilmington 138
Boston 130
Rome 129
Nanjing 121
Nürnberg 121
New York 119
Milan 111
Woodbridge 100
Fairfield 98
Marseille 94
Beijing 89
Princeton 86
Warsaw 81
Houston 79
Redwood City 79
Lawrence 64
Chicago 62
Dearborn 62
Izmir 56
Seattle 54
Nanchang 38
Hangzhou 36
Cambridge 35
Leawood 33
Pune 33
Munich 31
Boardman 29
Brussels 26
Shenyang 26
Augusta 24
Bremen 24
Redmond 24
Shanghai 24
London 23
Norwalk 23
Hebei 22
Helsinki 22
Hong Kong 21
Tianjin 21
Mountain View 20
Trieste 20
Zhengzhou 20
Changsha 19
Jiaxing 17
Kraków 17
University Park 17
Washington 17
Andover 16
Fremont 16
Kunming 16
Lancaster 15
Singapore 15
Falls Church 14
Ottawa 14
Verona 14
Kish 12
Bologna 11
Padova 11
Toronto 11
Guangzhou 10
Los Angeles 10
Naples 10
Busto Arsizio 9
Edinburgh 9
Genoa 9
Porto Alegre 9
Zurich 9
Brno 8
Seoul 8
Abidjan 7
Detroit 7
Ferrara 7
Hefei 7
Jinan 7
Lanzhou 7
Monmouth Junction 7
San Francisco 7
Simi Valley 7
Tokyo 7
Xian 7
Ceska 6
Chengdu 6
Lappeenranta 6
San Diego 6
San Jose 6
Atlanta 5
Berlin 5
Bern 5
Cagliari 5
Caserta 5
Changchun 5
Costa Mesa 5
Frankfurt am Main 5
Totale 5.368
Nome #
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 372
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 272
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 246
Wheat desensitization treatment in patients with gluten sensitivity 195
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 179
The role of intestinal microbiota and the immune system 172
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 169
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 166
The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial 154
White mulberry supplementation as adjuvant treatment of obesity 151
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 146
The role of diet on gut microbiota composition 133
Gut microbiota in autism and mood disorders 130
Nutritional aspects of Helicobacter pylori infection 127
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 127
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 125
13C-octanoic acid breath test to study gastric emptying time 125
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 125
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 124
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 124
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 123
Can chronic gastritis cause increase of fecal calprotectin concentrations? 122
Fecal microbiota transplantation: Past, present and future perspectives 118
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 117
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 110
Gut microbiota in autism and mood disorders 109
Assessment of neurological manifestations in hospitalized patients with COVID-19 108
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 105
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 104
Role of gut microbiota in food tolerance and allergies 101
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 98
Moderately Severe Acute Pancreatitis Associated With Riluzole 95
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features 94
Microscopic colitis 93
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 93
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease 89
Gut microbiota and metabolic syndrome 88
Role of N-acetyl-cisteine in the treatment of H. pylori 88
Coeliac disease: an old or a new disease? History of a pathology 88
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 88
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 85
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 85
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 84
European consensus conference on faecal microbiota transplantation in clinical practice 84
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. 83
Autism, gastrointestinal symptoms and modulation of gut microbiota by nutritional interventions 81
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 80
Detection of rare G3P[19] group A rotavirus in human patient, Italy 80
Levothyroxine absorption in health and disease, and new therapeutic perspectives 79
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 79
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 78
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 76
Pancreatic function assessment 73
The role of biomarkers in diverticular disease 73
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 72
Gut microbiome, big data and machine learning to promote precision medicine for cancer 70
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review 69
Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference 69
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 68
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial 68
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 67
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 65
Gut microbiota and inflammatory bowel disease: an update 65
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 64
Ipilimumab Adjuvant Therapy in Melanoma 63
The human gut microbiota and virome: Potential therapeutic implications 61
Helicobacter pylori in metabolic related diseases 59
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 57
How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection 55
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 54
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 54
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 54
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota 54
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 53
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 53
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement 50
Gut Virome and Inflammatory Bowel Disease 50
The gut microbiota: its anatomy and physiology during all life 50
Modulation of gut microbiota in patients with IBS and systemic nickel allergy after diet and probiotic supplementation: a pilot study 50
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 50
From Regular Catharsis with Castor Oil to Recognizing the Importance of the Intestinal Microbiota 49
Omega-3 fatty acids: a novel resort against gastrointestinal injury 48
Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? 48
Gastroenterology training in Europe: unmet educational needs beyond the machines 48
Digestive Enzyme Supplementation in Gastrointestinal Diseases 48
Antibiotics as deep modulators of gut microbiota: Between good and evil 47
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients 47
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 47
Gastric Microbiota 45
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 45
Endoscopic tools for the diagnosis and evaluation of celiac disease 44
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 44
Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models 44
FECAL CALPROTECTIN AND NEED OF MULTIPLE MICROBIOTA TRANSPLANTATION INFUSIONS IN CLOSTRIDIUM DIFFICILE INFECTION 44
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 44
Endoscopic tools for the diagnosis and evaluation of celiac disease 43
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 43
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 41
Gut and reproductive tract microbiota adaptation during pregnancy: New insights for pregnancy-related complications and therapy 41
Laboratory handling practice for faecal microbiota transplantation 41
Totale 8.958
Categoria #
all - tutte 41.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019233 0 0 0 0 0 0 0 0 0 68 102 63
2019/20201.329 250 96 72 95 96 115 147 58 92 65 145 98
2020/20211.147 62 121 29 97 140 97 124 26 120 80 196 55
2021/20221.358 77 77 37 77 92 66 41 217 55 81 271 267
2022/20233.069 404 384 225 436 185 372 152 266 371 81 109 84
2023/20241.534 99 478 93 110 86 270 169 92 53 84 0 0
Totale 10.953